Ozempic Doses: Understanding Your Personalized Treatment Journey

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

When you start semaglutide therapy, your dose typically begins at 0.25 mg weekly and may increase over several weeks to find your optimal level. PlexusDx designs personalized treatment plans by analyzing your unique genetic pathways, helping determine which medications and dosing strategies may work best for your individual physiology.

How Semaglutide Dosing Works in Clinical Practice

Semaglutide follows a titration schedule where your starting dose is intentionally low to allow your body to adjust to the medication's effects. Your healthcare provider evaluates your tolerance and weight loss progress at each step, then gradually increases your dose every 4 weeks. This cautious approach helps minimize nausea and side effects while your system adapts to the GLP-1 receptor signaling in your brain and digestive system.

The standard escalation pattern moves from 0.25 mg to 0.5 mg, then 1.0 mg, and potentially up to 2.4 mg weekly, depending on your response and goals. However, not everyone needs the maximum dose to achieve meaningful results. Some patients experience significant appetite suppression and steady weight loss at intermediate doses, while others may benefit from reaching higher levels for greater metabolic impact.

Your individual dose is determined by clinical assessment—not a preset formula. Factors including your baseline weight, metabolism, tolerance to gastrointestinal effects, and whether you have type 2 diabetes all influence your treatment trajectory. PlexusDx works with licensed 503A compounding pharmacies to deliver your personalized semaglutide regimen at flat monthly pricing, so your dose may need to go up, but your price won't.

Why Genetic Factors Shape Your Semaglutide Response

Your genetic makeup influences how effectively semaglutide works by controlling the density and sensitivity of GLP-1 receptors throughout your body. The GLP1R gene, particularly the rs6923761 variant, affects how many receptors your cells express and how strongly they respond to the medication. People with different genetic profiles at this locus may experience different appetite suppression intensity and weight loss timelines at identical doses.

The PlexusDx Precision Peptide Genetic Test analyzes FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The Precision Peptide Genetic Test analyzes 14 distinct peptide pathways involving 49 peptides and 150+ genetic insights, moving beyond traditional pharmacogenomics to map your personalized GLP-1 and appetite regulation biology. This $99 add-on test, completed after your first month of treatment, reveals your unique genetic risk factors and receptor sensitivities, enabling your provider to optimize dosing and medication selection based on solid scientific evidence about your body's actual biochemistry.

Tracking Progress: When to Expect Dose Adjustments

Most patients remain on each dose level for 4 weeks before moving to the next tier, allowing sufficient time to assess weight loss, appetite changes, and side effect tolerance. During this period, you'll typically notice reduced hunger and increased food satisfaction with smaller portions. Your healthcare provider monitors your progress through regular check-ins, and you provide feedback on how you're feeling, energy levels, and any gastrointestinal symptoms.

Weight loss typically accelerates after 8 to 12 weeks as your dose reaches therapeutic levels and your body adapts to semaglutide's appetite-suppressing effects. Some patients plateau earlier than others, which may signal that your current dose is optimal for your genetic profile and lifestyle. Conversely, if you're tolerating the medication well and weight loss is still progressing steadily, your provider may continue titration to maximize your results.

PlexusDx provides access to compounded semaglutide injections starting at $189/mo (or $149/mo on the 6-month plan) with flat pricing across all dose levels. This pricing structure means you're never charged more as your therapeutic dose increases—your medication cost remains predictable while you work with your provider to find your personal optimal dose. HSA and FSA accounts are eligible for coverage, making personalized therapy more accessible regardless of insurance status.

Personalized Alternatives if Semaglutide Isn't Your Best Option

The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx offers compounded tirzepatide injections starting at $289/mo (or $249/mo on the 6-month plan), as well as combination therapy called GLP-Squared Injection (semaglutide plus tirzepatide) starting at $289/mo (or $249/mo on the 3-month plan). A microdose GLP-1 protocol is also available at $129 per month for patients seeking a gentler introduction or those with sensitivity to standard doses. Your Precision Peptide Genetic Test results guide these personalization decisions, helping you avoid costly trial-and-error by predicting which medication framework aligns with your genetic receptor makeup.

All PlexusDx medications come from licensed 503A compounding pharmacies serving all 50 states without requiring insurance or membership fees. Your personalized dose adjustment journey is supported by clinical expertise and genetic insights, ensuring that you find the right medication at the right dose to achieve your individual health goals sustainably.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test starts at $99 add-on. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide, and how quickly does it increase?

Semaglutide therapy typically begins at 0.25 mg weekly and increases by 0.25 mg every 4 weeks until reaching your optimal therapeutic dose, which may be 1.0 mg, 1.7 mg, or 2.4 mg weekly depending on your individual response. PlexusDx works with your provider to time these adjustments based on your tolerance and weight loss progress, ensuring a personalized escalation timeline that matches your body's needs.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Will my monthly cost increase as my semaglutide dose goes up?

No. PlexusDx prices compounded semaglutide at a flat monthly rate starting at $189, with no additional charges as your therapeutic dose increases. This means your dose may need to go up, but your price won't—providing budget predictability throughout your personalized treatment journey.

What if semaglutide at higher doses causes too many side effects?

If you experience persistent nausea, vomiting, or other side effects at standard doses, your provider may reduce your dose to a lower therapeutic level or switch you to an alternative medication. PlexusDx offers compounded tirzepatide, microdose GLP-1 protocol, and GLP-Squared combination therapy—all designed to activate your appetite and metabolic pathways through different mechanisms. Your genetic test results can guide these decisions.

How does the Precision Peptide Genetic Test help personalize my semaglutide treatment?

The test identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R genes across 14 peptide pathways, revealing whether you're likely a strong responder to semaglutide, a candidate for dual-receptor therapy like tirzepatide, or better suited to a microdose approach. At $99 as an add-on after your first month, this insight helps your provider optimize dosing and medication selection based on your unique biochemistry rather than guesswork.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.